Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • tax inversion

    - PMLiVE

    Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients

    Over 800,000 people worldwide live with haemophilia

    - PMLiVE

    Pfizer’s PADCEV gets FDA approval for bladder cancer

    Bladder cancer affects more than 614,000 people globally each year

    - PMLiVE

    Pfizer and Metsera agree on merger after bidding war between Pfizer and Novo Nordisk

    The Pfizer bid was chosen by Metsera after a concern was raised about US antitrust laws regarding the Novo Nordisk offer

    - PMLiVE

    Pfizer’s Lorviqua recommended by NICE for lung cancer

    Lung cancer is the leading cause of cancer-related deaths worldwide

    - PMLiVE

    Pfizer agrees pricing and distribution deal with US government

    The agreement enables US patients to access medicines at a discount, in addition to providing Pfizer with relief from US tariffs

    - PMLiVE

    Pfizer/Astellas share positive overall survival results for Xtandi in prostate cancer

    Around 55,100 cases of prostate cancer are diagnosed in the UK every year

    - PMLiVE

    Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi

    Around 20% and 3% of haemophilia A and B patients, respectively, develop inhibitors

    - PMLiVE

    Pfizer shares ‘unprecedented’ survival results for Braftovi in colorectal cancer

    Around 154,270 people are expected to be diagnosed with cancer of the colon or rectum in the US this year

    - PMLiVE

    Pfizer gains rights to 3SBio’s investigational bispecific antibody in deal worth over $6bn

    The candidate is in clinical development for colorectal cancer, lung cancer and gynaecological tumours

    - PMLiVE

    Pfizer’s sasanlimab improves event-free survival in phase 3 bladder cancer trial

    As many as half of patients with high-risk NMIBC experience disease recurrence despite BCG treatment

    - PMLiVE

    Pfizer’s Hympavzi granted MHRA approval to treat haemophilia A and B

    More than 11,800 people were living with the genetic blood disorders in the UK in 2023/2024

    - PMLiVE

    Pfizer and Flagship Pioneering enter autoimmune disease partnership

    More than 100 known types of autoimmune diseases affect over 50 million people in the US

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links